nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—CYP2B6—Rifampicin—leprosy	0.142	0.227	CbGbCtD
Paroxetine—CYP2C8—Rifampicin—leprosy	0.107	0.172	CbGbCtD
Paroxetine—CYP2C8—Dapsone—leprosy	0.0885	0.142	CbGbCtD
Paroxetine—CYP2C9—Thalidomide—leprosy	0.0772	0.124	CbGbCtD
Paroxetine—CYP2C9—Rifampicin—leprosy	0.0748	0.12	CbGbCtD
Paroxetine—ABCB1—Rifampicin—leprosy	0.0725	0.116	CbGbCtD
Paroxetine—CYP2C9—Dapsone—leprosy	0.0617	0.099	CbGbCtD
Paroxetine—TACR1—trigeminal nerve—leprosy	0.0206	0.185	CbGeAlD
Paroxetine—TACR1—cranial nerve—leprosy	0.0147	0.132	CbGeAlD
Paroxetine—TACR1—peripheral nervous system—leprosy	0.00966	0.0866	CbGeAlD
Paroxetine—TACR1—nerve—leprosy	0.00753	0.0675	CbGeAlD
Paroxetine—CHRM5—skin epidermis—leprosy	0.0065	0.0582	CbGeAlD
Paroxetine—HTR2A—trigeminal nerve—leprosy	0.00503	0.0451	CbGeAlD
Paroxetine—SLC6A3—nerve—leprosy	0.00379	0.0339	CbGeAlD
Paroxetine—HTR2A—cranial nerve—leprosy	0.00358	0.0321	CbGeAlD
Paroxetine—SLC6A2—nerve—leprosy	0.00306	0.0274	CbGeAlD
Paroxetine—HTR2A—hindlimb—leprosy	0.00302	0.0271	CbGeAlD
Paroxetine—HTR2A—appendage—leprosy	0.00259	0.0232	CbGeAlD
Paroxetine—HTR2A—peripheral nervous system—leprosy	0.00236	0.0211	CbGeAlD
Paroxetine—CHRM5—eye—leprosy	0.00231	0.0207	CbGeAlD
Paroxetine—CHRM5—skin of body—leprosy	0.00201	0.018	CbGeAlD
Paroxetine—Lymphopenia—Thalidomide—leprosy	0.00188	0.0071	CcSEcCtD
Paroxetine—Nuchal rigidity—Thalidomide—leprosy	0.00186	0.007	CcSEcCtD
Paroxetine—HTR2A—nerve—leprosy	0.00184	0.0165	CbGeAlD
Paroxetine—Hostility—Thalidomide—leprosy	0.00174	0.00656	CcSEcCtD
Paroxetine—TACR1—testis—leprosy	0.00173	0.0155	CbGeAlD
Paroxetine—Sexual dysfunction—Thalidomide—leprosy	0.00172	0.00648	CcSEcCtD
Paroxetine—Vesiculobullous rash—Thalidomide—leprosy	0.00172	0.00648	CcSEcCtD
Paroxetine—Suicide attempt—Thalidomide—leprosy	0.0017	0.0064	CcSEcCtD
Paroxetine—TACR1—nervous system—leprosy	0.00169	0.0152	CbGeAlD
Paroxetine—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00166	0.00625	CcSEcCtD
Paroxetine—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.00166	0.00625	CcSEcCtD
Paroxetine—Gastric ulcer—Thalidomide—leprosy	0.00166	0.00625	CcSEcCtD
Paroxetine—CHRM4—testis—leprosy	0.00162	0.0145	CbGeAlD
Paroxetine—CHRM4—nervous system—leprosy	0.00159	0.0143	CbGeAlD
Paroxetine—Toothache—Thalidomide—leprosy	0.00158	0.00597	CcSEcCtD
Paroxetine—Myasthenia—Thalidomide—leprosy	0.00153	0.00578	CcSEcCtD
Paroxetine—Hypothyroidism—Thalidomide—leprosy	0.0015	0.00566	CcSEcCtD
Paroxetine—Tooth disorder—Thalidomide—leprosy	0.00148	0.0056	CcSEcCtD
Paroxetine—Galactorrhoea—Thalidomide—leprosy	0.00148	0.0056	CcSEcCtD
Paroxetine—HTR2A—blood vessel—leprosy	0.00144	0.0129	CbGeAlD
Paroxetine—Intestinal obstruction—Thalidomide—leprosy	0.00141	0.00533	CcSEcCtD
Paroxetine—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00141	0.00533	CcSEcCtD
Paroxetine—Menstrual disorder—Thalidomide—leprosy	0.00141	0.00533	CcSEcCtD
Paroxetine—Neuralgia—Thalidomide—leprosy	0.00139	0.00523	CcSEcCtD
Paroxetine—Hypercalcaemia—Thalidomide—leprosy	0.00139	0.00523	CcSEcCtD
Paroxetine—Thrombosis—Thalidomide—leprosy	0.00136	0.00513	CcSEcCtD
Paroxetine—Metrorrhagia—Thalidomide—leprosy	0.00135	0.00509	CcSEcCtD
Paroxetine—Nystagmus—Thalidomide—leprosy	0.00135	0.00509	CcSEcCtD
Paroxetine—Psychotic disorder—Dapsone—leprosy	0.00133	0.00503	CcSEcCtD
Paroxetine—Stupor—Thalidomide—leprosy	0.00129	0.00487	CcSEcCtD
Paroxetine—Neuritis—Thalidomide—leprosy	0.00129	0.00487	CcSEcCtD
Paroxetine—Albuminuria—Thalidomide—leprosy	0.00129	0.00487	CcSEcCtD
Paroxetine—Amblyopia—Thalidomide—leprosy	0.00125	0.0047	CcSEcCtD
Paroxetine—CHRM5—nervous system—leprosy	0.00124	0.0112	CbGeAlD
Paroxetine—Skin ulcer—Thalidomide—leprosy	0.00124	0.00467	CcSEcCtD
Paroxetine—Hyperaesthesia—Thalidomide—leprosy	0.00123	0.00463	CcSEcCtD
Paroxetine—Nasopharyngitis—Dapsone—leprosy	0.00122	0.00461	CcSEcCtD
Paroxetine—Rash pustular—Thalidomide—leprosy	0.00121	0.00456	CcSEcCtD
Paroxetine—Muscular weakness—Dapsone—leprosy	0.0012	0.00454	CcSEcCtD
Paroxetine—Myocardial ischaemia—Thalidomide—leprosy	0.0012	0.00452	CcSEcCtD
Paroxetine—Influenza—Dapsone—leprosy	0.00118	0.00445	CcSEcCtD
Paroxetine—Endocrine disorder—Thalidomide—leprosy	0.00116	0.00438	CcSEcCtD
Paroxetine—Pancreatitis—Dapsone—leprosy	0.00116	0.00437	CcSEcCtD
Paroxetine—Acne—Thalidomide—leprosy	0.00114	0.00432	CcSEcCtD
Paroxetine—Vasodilation—Thalidomide—leprosy	0.0011	0.00413	CcSEcCtD
Paroxetine—Vasodilation procedure—Thalidomide—leprosy	0.0011	0.00413	CcSEcCtD
Paroxetine—Amenorrhoea—Thalidomide—leprosy	0.0011	0.00413	CcSEcCtD
Paroxetine—Photosensitivity reaction—Dapsone—leprosy	0.00108	0.00406	CcSEcCtD
Paroxetine—Musculoskeletal stiffness—Thalidomide—leprosy	0.00107	0.00405	CcSEcCtD
Paroxetine—Skin discolouration—Thalidomide—leprosy	0.00107	0.00402	CcSEcCtD
Paroxetine—Bone disorder—Thalidomide—leprosy	0.00107	0.00402	CcSEcCtD
Paroxetine—Hyperbilirubinaemia—Thalidomide—leprosy	0.00106	0.004	CcSEcCtD
Paroxetine—Cellulitis—Thalidomide—leprosy	0.00106	0.004	CcSEcCtD
Paroxetine—Arthropathy—Thalidomide—leprosy	0.00106	0.004	CcSEcCtD
Paroxetine—Thinking abnormal—Thalidomide—leprosy	0.00105	0.00397	CcSEcCtD
Paroxetine—Hypocalcaemia—Thalidomide—leprosy	0.00105	0.00397	CcSEcCtD
Paroxetine—Oliguria—Thalidomide—leprosy	0.00104	0.00394	CcSEcCtD
Paroxetine—Herpes simplex—Thalidomide—leprosy	0.00104	0.00394	CcSEcCtD
Paroxetine—Neuropathy peripheral—Dapsone—leprosy	0.00103	0.00389	CcSEcCtD
Paroxetine—Leukocytosis—Thalidomide—leprosy	0.00102	0.00387	CcSEcCtD
Paroxetine—Dyskinesia—Thalidomide—leprosy	0.00102	0.00387	CcSEcCtD
Paroxetine—Hypercholesterolaemia—Thalidomide—leprosy	0.00102	0.00384	CcSEcCtD
Paroxetine—Atrioventricular block—Thalidomide—leprosy	0.000993	0.00375	CcSEcCtD
Paroxetine—Sinusitis—Dapsone—leprosy	0.000987	0.00372	CcSEcCtD
Paroxetine—Gait disturbance—Thalidomide—leprosy	0.000986	0.00372	CcSEcCtD
Paroxetine—Coordination abnormal—Thalidomide—leprosy	0.00098	0.0037	CcSEcCtD
Paroxetine—Neck pain—Thalidomide—leprosy	0.000974	0.00368	CcSEcCtD
Paroxetine—Pulmonary embolism—Thalidomide—leprosy	0.000963	0.00363	CcSEcCtD
Paroxetine—Phosphatase alkaline increased—Thalidomide—leprosy	0.000963	0.00363	CcSEcCtD
Paroxetine—Hyperkalaemia—Thalidomide—leprosy	0.000946	0.00357	CcSEcCtD
Paroxetine—Eructation—Thalidomide—leprosy	0.000946	0.00357	CcSEcCtD
Paroxetine—ABCB1—blood vessel—leprosy	0.000945	0.00847	CbGeAlD
Paroxetine—Pharyngitis—Dapsone—leprosy	0.000937	0.00354	CcSEcCtD
Paroxetine—Depressed level of consciousness—Thalidomide—leprosy	0.00093	0.00351	CcSEcCtD
Paroxetine—Colitis—Thalidomide—leprosy	0.000924	0.00349	CcSEcCtD
Paroxetine—Candida infection—Thalidomide—leprosy	0.000919	0.00347	CcSEcCtD
Paroxetine—Blood urea increased—Thalidomide—leprosy	0.000909	0.00343	CcSEcCtD
Paroxetine—Aplastic anaemia—Thalidomide—leprosy	0.000904	0.00341	CcSEcCtD
Paroxetine—Neuropathy—Thalidomide—leprosy	0.000904	0.00341	CcSEcCtD
Paroxetine—Tinnitus—Dapsone—leprosy	0.000881	0.00332	CcSEcCtD
Paroxetine—Oesophagitis—Thalidomide—leprosy	0.00088	0.00332	CcSEcCtD
Paroxetine—Rash maculo-papular—Thalidomide—leprosy	0.000875	0.0033	CcSEcCtD
Paroxetine—SLC6A3—testis—leprosy	0.000868	0.00778	CbGeAlD
Paroxetine—Lightheadedness—Thalidomide—leprosy	0.000861	0.00325	CcSEcCtD
Paroxetine—Pulmonary oedema—Thalidomide—leprosy	0.000857	0.00323	CcSEcCtD
Paroxetine—CHRM2—nervous system—leprosy	0.000855	0.00766	CbGeAlD
Paroxetine—SLC6A3—nervous system—leprosy	0.000852	0.00763	CbGeAlD
Paroxetine—Hypertonia—Thalidomide—leprosy	0.000844	0.00318	CcSEcCtD
Paroxetine—Hyperkinesia—Thalidomide—leprosy	0.00084	0.00317	CcSEcCtD
Paroxetine—Sepsis—Thalidomide—leprosy	0.000835	0.00315	CcSEcCtD
Paroxetine—Mental disability—Thalidomide—leprosy	0.000835	0.00315	CcSEcCtD
Paroxetine—Euphoric mood—Thalidomide—leprosy	0.000827	0.00312	CcSEcCtD
Paroxetine—Erythema—Dapsone—leprosy	0.000822	0.0031	CcSEcCtD
Paroxetine—Lymphadenopathy—Thalidomide—leprosy	0.000819	0.00309	CcSEcCtD
Paroxetine—CYP2B6—skin of body—leprosy	0.000819	0.00734	CbGeAlD
Paroxetine—Thrombophlebitis—Thalidomide—leprosy	0.000807	0.00305	CcSEcCtD
Paroxetine—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000803	0.00303	CcSEcCtD
Paroxetine—Diabetes mellitus—Thalidomide—leprosy	0.000803	0.00303	CcSEcCtD
Paroxetine—Photosensitivity—Thalidomide—leprosy	0.000796	0.003	CcSEcCtD
Paroxetine—Gastroenteritis—Thalidomide—leprosy	0.000788	0.00298	CcSEcCtD
Paroxetine—Vascular purpura—Thalidomide—leprosy	0.000781	0.00295	CcSEcCtD
Paroxetine—Deafness—Thalidomide—leprosy	0.000781	0.00295	CcSEcCtD
Paroxetine—SLC6A4—nervous system—leprosy	0.000781	0.007	CbGeAlD
Paroxetine—CHRM1—nervous system—leprosy	0.000778	0.00697	CbGeAlD
Paroxetine—Eczema—Thalidomide—leprosy	0.000778	0.00293	CcSEcCtD
Paroxetine—Vision blurred—Dapsone—leprosy	0.000775	0.00292	CcSEcCtD
Paroxetine—Eye pain—Thalidomide—leprosy	0.000774	0.00292	CcSEcCtD
Paroxetine—Cardiac failure congestive—Thalidomide—leprosy	0.000771	0.00291	CcSEcCtD
Paroxetine—HTR2A—eye—leprosy	0.000768	0.00688	CbGeAlD
Paroxetine—Injury—Thalidomide—leprosy	0.00076	0.00287	CcSEcCtD
Paroxetine—Renal failure acute—Thalidomide—leprosy	0.000757	0.00286	CcSEcCtD
Paroxetine—Libido decreased—Thalidomide—leprosy	0.000754	0.00284	CcSEcCtD
Paroxetine—Increased appetite—Thalidomide—leprosy	0.000744	0.00281	CcSEcCtD
Paroxetine—Amnesia—Thalidomide—leprosy	0.000744	0.00281	CcSEcCtD
Paroxetine—Dermatitis exfoliative—Thalidomide—leprosy	0.000741	0.00279	CcSEcCtD
Paroxetine—Vertigo—Dapsone—leprosy	0.000739	0.00279	CcSEcCtD
Paroxetine—Atrial fibrillation—Thalidomide—leprosy	0.000737	0.00278	CcSEcCtD
Paroxetine—Visual disturbance—Thalidomide—leprosy	0.000737	0.00278	CcSEcCtD
Paroxetine—Dermatitis bullous—Thalidomide—leprosy	0.000731	0.00276	CcSEcCtD
Paroxetine—Purpura—Thalidomide—leprosy	0.000725	0.00274	CcSEcCtD
Paroxetine—Arthritis—Thalidomide—leprosy	0.000719	0.00271	CcSEcCtD
Paroxetine—Cough—Dapsone—leprosy	0.000717	0.00271	CcSEcCtD
Paroxetine—Hypoglycaemia—Thalidomide—leprosy	0.000716	0.0027	CcSEcCtD
Paroxetine—Lethargy—Thalidomide—leprosy	0.000713	0.00269	CcSEcCtD
Paroxetine—Cerebrovascular accident—Thalidomide—leprosy	0.000713	0.00269	CcSEcCtD
Paroxetine—CHRM3—testis—leprosy	0.000709	0.00635	CbGeAlD
Paroxetine—Hyponatraemia—Thalidomide—leprosy	0.000702	0.00265	CcSEcCtD
Paroxetine—SLC6A2—testis—leprosy	0.0007	0.00627	CbGeAlD
Paroxetine—Diplopia—Thalidomide—leprosy	0.000699	0.00264	CcSEcCtD
Paroxetine—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000699	0.00264	CcSEcCtD
Paroxetine—Osteoarthritis—Thalidomide—leprosy	0.000699	0.00264	CcSEcCtD
Paroxetine—CHRM3—nervous system—leprosy	0.000696	0.00624	CbGeAlD
Paroxetine—Disturbance in sexual arousal—Thalidomide—leprosy	0.000693	0.00262	CcSEcCtD
Paroxetine—Affect lability—Thalidomide—leprosy	0.000688	0.0026	CcSEcCtD
Paroxetine—Migraine—Thalidomide—leprosy	0.000688	0.0026	CcSEcCtD
Paroxetine—SLC6A2—nervous system—leprosy	0.000687	0.00616	CbGeAlD
Paroxetine—Psychotic disorder—Thalidomide—leprosy	0.000683	0.00258	CcSEcCtD
Paroxetine—Face oedema—Thalidomide—leprosy	0.000675	0.00255	CcSEcCtD
Paroxetine—Mood swings—Thalidomide—leprosy	0.000662	0.0025	CcSEcCtD
Paroxetine—Ataxia—Thalidomide—leprosy	0.000657	0.00248	CcSEcCtD
Paroxetine—Tachycardia—Dapsone—leprosy	0.000655	0.00247	CcSEcCtD
Paroxetine—Dehydration—Thalidomide—leprosy	0.00065	0.00245	CcSEcCtD
Paroxetine—Liver function test abnormal—Thalidomide—leprosy	0.000645	0.00243	CcSEcCtD
Paroxetine—Dry skin—Thalidomide—leprosy	0.000641	0.00242	CcSEcCtD
Paroxetine—Orthostatic hypotension—Thalidomide—leprosy	0.000638	0.00241	CcSEcCtD
Paroxetine—Hypokalaemia—Thalidomide—leprosy	0.000636	0.0024	CcSEcCtD
Paroxetine—Breast disorder—Thalidomide—leprosy	0.000632	0.00238	CcSEcCtD
Paroxetine—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000629	0.00237	CcSEcCtD
Paroxetine—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000629	0.00237	CcSEcCtD
Paroxetine—Cramp muscle—Thalidomide—leprosy	0.000629	0.00237	CcSEcCtD
Paroxetine—Alanine aminotransferase increased—Thalidomide—leprosy	0.000616	0.00233	CcSEcCtD
Paroxetine—Muscular weakness—Thalidomide—leprosy	0.000616	0.00233	CcSEcCtD
Paroxetine—Insomnia—Dapsone—leprosy	0.000607	0.00229	CcSEcCtD
Paroxetine—Influenza—Thalidomide—leprosy	0.000604	0.00228	CcSEcCtD
Paroxetine—Dysphagia—Thalidomide—leprosy	0.000604	0.00228	CcSEcCtD
Paroxetine—Eosinophilia—Thalidomide—leprosy	0.000598	0.00226	CcSEcCtD
Paroxetine—Pancreatitis—Thalidomide—leprosy	0.000592	0.00223	CcSEcCtD
Paroxetine—Angina pectoris—Thalidomide—leprosy	0.000588	0.00222	CcSEcCtD
Paroxetine—Bronchitis—Thalidomide—leprosy	0.000581	0.00219	CcSEcCtD
Paroxetine—CYP2C8—testis—leprosy	0.000575	0.00515	CbGeAlD
Paroxetine—Pancytopenia—Thalidomide—leprosy	0.000574	0.00216	CcSEcCtD
Paroxetine—Pollakiuria—Thalidomide—leprosy	0.000558	0.00211	CcSEcCtD
Paroxetine—Erectile dysfunction—Thalidomide—leprosy	0.000556	0.0021	CcSEcCtD
Paroxetine—Photosensitivity reaction—Thalidomide—leprosy	0.000551	0.00208	CcSEcCtD
Paroxetine—Weight increased—Thalidomide—leprosy	0.00055	0.00207	CcSEcCtD
Paroxetine—Gastrointestinal pain—Dapsone—leprosy	0.000549	0.00207	CcSEcCtD
Paroxetine—Weight decreased—Thalidomide—leprosy	0.000546	0.00206	CcSEcCtD
Paroxetine—Hyperglycaemia—Thalidomide—leprosy	0.000545	0.00206	CcSEcCtD
Paroxetine—Pneumonia—Thalidomide—leprosy	0.000542	0.00204	CcSEcCtD
Paroxetine—Drowsiness—Thalidomide—leprosy	0.000539	0.00203	CcSEcCtD
Paroxetine—Depression—Thalidomide—leprosy	0.000537	0.00203	CcSEcCtD
Paroxetine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000534	0.00201	CcSEcCtD
Paroxetine—Acute coronary syndrome—Thalidomide—leprosy	0.000531	0.002	CcSEcCtD
Paroxetine—Body temperature increased—Dapsone—leprosy	0.00053	0.002	CcSEcCtD
Paroxetine—Abdominal pain—Dapsone—leprosy	0.00053	0.002	CcSEcCtD
Paroxetine—Myocardial infarction—Thalidomide—leprosy	0.000528	0.00199	CcSEcCtD
Paroxetine—Neuropathy peripheral—Thalidomide—leprosy	0.000528	0.00199	CcSEcCtD
Paroxetine—Stomatitis—Thalidomide—leprosy	0.000525	0.00198	CcSEcCtD
Paroxetine—Conjunctivitis—Thalidomide—leprosy	0.000523	0.00198	CcSEcCtD
Paroxetine—Sweating—Thalidomide—leprosy	0.000516	0.00195	CcSEcCtD
Paroxetine—CYP2B6—testis—leprosy	0.000516	0.00462	CbGeAlD
Paroxetine—Haematuria—Thalidomide—leprosy	0.000513	0.00194	CcSEcCtD
Paroxetine—HTR2A—tendon—leprosy	0.000508	0.00455	CbGeAlD
Paroxetine—Epistaxis—Thalidomide—leprosy	0.000508	0.00192	CcSEcCtD
Paroxetine—CYP2B6—nervous system—leprosy	0.000507	0.00454	CbGeAlD
Paroxetine—Sinusitis—Thalidomide—leprosy	0.000505	0.00191	CcSEcCtD
Paroxetine—Agranulocytosis—Thalidomide—leprosy	0.000503	0.0019	CcSEcCtD
Paroxetine—Bradycardia—Thalidomide—leprosy	0.000492	0.00186	CcSEcCtD
Paroxetine—Rhinitis—Thalidomide—leprosy	0.000485	0.00183	CcSEcCtD
Paroxetine—Hepatitis—Thalidomide—leprosy	0.000483	0.00182	CcSEcCtD
Paroxetine—Hypoaesthesia—Thalidomide—leprosy	0.000481	0.00182	CcSEcCtD
Paroxetine—Pharyngitis—Thalidomide—leprosy	0.00048	0.00181	CcSEcCtD
Paroxetine—Oedema peripheral—Thalidomide—leprosy	0.000476	0.0018	CcSEcCtD
Paroxetine—Visual impairment—Thalidomide—leprosy	0.000466	0.00176	CcSEcCtD
Paroxetine—Erythema multiforme—Thalidomide—leprosy	0.000457	0.00172	CcSEcCtD
Paroxetine—Eye disorder—Thalidomide—leprosy	0.000452	0.0017	CcSEcCtD
Paroxetine—Tinnitus—Thalidomide—leprosy	0.000451	0.0017	CcSEcCtD
Paroxetine—Cardiac disorder—Thalidomide—leprosy	0.000449	0.00169	CcSEcCtD
Paroxetine—Angiopathy—Thalidomide—leprosy	0.000439	0.00166	CcSEcCtD
Paroxetine—Immune system disorder—Thalidomide—leprosy	0.000437	0.00165	CcSEcCtD
Paroxetine—Mediastinal disorder—Thalidomide—leprosy	0.000436	0.00164	CcSEcCtD
Paroxetine—Chills—Thalidomide—leprosy	0.000434	0.00164	CcSEcCtD
Paroxetine—Arrhythmia—Thalidomide—leprosy	0.000432	0.00163	CcSEcCtD
Paroxetine—Alopecia—Thalidomide—leprosy	0.000427	0.00161	CcSEcCtD
Paroxetine—Vomiting—Dapsone—leprosy	0.000427	0.00161	CcSEcCtD
Paroxetine—Mental disorder—Thalidomide—leprosy	0.000424	0.0016	CcSEcCtD
Paroxetine—HTR2A—testis—leprosy	0.000421	0.00377	CbGeAlD
Paroxetine—Malnutrition—Thalidomide—leprosy	0.000421	0.00159	CcSEcCtD
Paroxetine—Headache—Dapsone—leprosy	0.00042	0.00159	CcSEcCtD
Paroxetine—Flatulence—Thalidomide—leprosy	0.000415	0.00156	CcSEcCtD
Paroxetine—HTR2A—nervous system—leprosy	0.000413	0.0037	CbGeAlD
Paroxetine—Tension—Thalidomide—leprosy	0.000413	0.00156	CcSEcCtD
Paroxetine—Dysgeusia—Thalidomide—leprosy	0.000412	0.00156	CcSEcCtD
Paroxetine—Nervousness—Thalidomide—leprosy	0.000409	0.00154	CcSEcCtD
Paroxetine—Back pain—Thalidomide—leprosy	0.000407	0.00154	CcSEcCtD
Paroxetine—Muscle spasms—Thalidomide—leprosy	0.000405	0.00153	CcSEcCtD
Paroxetine—Nausea—Dapsone—leprosy	0.000399	0.0015	CcSEcCtD
Paroxetine—Vision blurred—Thalidomide—leprosy	0.000397	0.0015	CcSEcCtD
Paroxetine—Tremor—Thalidomide—leprosy	0.000394	0.00149	CcSEcCtD
Paroxetine—Ill-defined disorder—Thalidomide—leprosy	0.00039	0.00147	CcSEcCtD
Paroxetine—Anaemia—Thalidomide—leprosy	0.000389	0.00147	CcSEcCtD
Paroxetine—Agitation—Thalidomide—leprosy	0.000387	0.00146	CcSEcCtD
Paroxetine—Angioedema—Thalidomide—leprosy	0.000385	0.00145	CcSEcCtD
Paroxetine—CYP2D6—testis—leprosy	0.000384	0.00344	CbGeAlD
Paroxetine—Malaise—Thalidomide—leprosy	0.00038	0.00143	CcSEcCtD
Paroxetine—Vertigo—Thalidomide—leprosy	0.000378	0.00143	CcSEcCtD
Paroxetine—Syncope—Thalidomide—leprosy	0.000377	0.00142	CcSEcCtD
Paroxetine—Leukopenia—Thalidomide—leprosy	0.000377	0.00142	CcSEcCtD
Paroxetine—CYP2D6—nervous system—leprosy	0.000376	0.00337	CbGeAlD
Paroxetine—Palpitations—Thalidomide—leprosy	0.000372	0.0014	CcSEcCtD
Paroxetine—Loss of consciousness—Thalidomide—leprosy	0.00037	0.0014	CcSEcCtD
Paroxetine—Cough—Thalidomide—leprosy	0.000367	0.00139	CcSEcCtD
Paroxetine—Convulsion—Thalidomide—leprosy	0.000365	0.00138	CcSEcCtD
Paroxetine—Hypertension—Thalidomide—leprosy	0.000363	0.00137	CcSEcCtD
Paroxetine—Arthralgia—Thalidomide—leprosy	0.000358	0.00135	CcSEcCtD
Paroxetine—Chest pain—Thalidomide—leprosy	0.000358	0.00135	CcSEcCtD
Paroxetine—Myalgia—Thalidomide—leprosy	0.000358	0.00135	CcSEcCtD
Paroxetine—Anxiety—Thalidomide—leprosy	0.000357	0.00135	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000356	0.00134	CcSEcCtD
Paroxetine—Discomfort—Thalidomide—leprosy	0.000354	0.00134	CcSEcCtD
Paroxetine—Dry mouth—Thalidomide—leprosy	0.00035	0.00132	CcSEcCtD
Paroxetine—Confusional state—Thalidomide—leprosy	0.000346	0.00131	CcSEcCtD
Paroxetine—Oedema—Thalidomide—leprosy	0.000343	0.0013	CcSEcCtD
Paroxetine—Infection—Thalidomide—leprosy	0.000341	0.00129	CcSEcCtD
Paroxetine—Shock—Thalidomide—leprosy	0.000338	0.00128	CcSEcCtD
Paroxetine—Nervous system disorder—Thalidomide—leprosy	0.000337	0.00127	CcSEcCtD
Paroxetine—Thrombocytopenia—Thalidomide—leprosy	0.000336	0.00127	CcSEcCtD
Paroxetine—Tachycardia—Thalidomide—leprosy	0.000335	0.00127	CcSEcCtD
Paroxetine—Skin disorder—Thalidomide—leprosy	0.000334	0.00126	CcSEcCtD
Paroxetine—Hyperhidrosis—Thalidomide—leprosy	0.000332	0.00125	CcSEcCtD
Paroxetine—Hypotension—Thalidomide—leprosy	0.000321	0.00121	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000313	0.00118	CcSEcCtD
Paroxetine—Insomnia—Thalidomide—leprosy	0.000311	0.00117	CcSEcCtD
Paroxetine—Paraesthesia—Thalidomide—leprosy	0.000308	0.00116	CcSEcCtD
Paroxetine—Dyspnoea—Thalidomide—leprosy	0.000306	0.00116	CcSEcCtD
Paroxetine—Somnolence—Thalidomide—leprosy	0.000305	0.00115	CcSEcCtD
Paroxetine—Dyspepsia—Thalidomide—leprosy	0.000302	0.00114	CcSEcCtD
Paroxetine—Decreased appetite—Thalidomide—leprosy	0.000299	0.00113	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Thalidomide—leprosy	0.000297	0.00112	CcSEcCtD
Paroxetine—Fatigue—Thalidomide—leprosy	0.000296	0.00112	CcSEcCtD
Paroxetine—Pain—Thalidomide—leprosy	0.000294	0.00111	CcSEcCtD
Paroxetine—Constipation—Thalidomide—leprosy	0.000294	0.00111	CcSEcCtD
Paroxetine—Feeling abnormal—Thalidomide—leprosy	0.000283	0.00107	CcSEcCtD
Paroxetine—Gastrointestinal pain—Thalidomide—leprosy	0.000281	0.00106	CcSEcCtD
Paroxetine—ABCB1—testis—leprosy	0.000276	0.00247	CbGeAlD
Paroxetine—Urticaria—Thalidomide—leprosy	0.000273	0.00103	CcSEcCtD
Paroxetine—Body temperature increased—Thalidomide—leprosy	0.000272	0.00102	CcSEcCtD
Paroxetine—Abdominal pain—Thalidomide—leprosy	0.000272	0.00102	CcSEcCtD
Paroxetine—ABCB1—nervous system—leprosy	0.000271	0.00243	CbGeAlD
Paroxetine—Hypersensitivity—Thalidomide—leprosy	0.000253	0.000955	CcSEcCtD
Paroxetine—Asthenia—Thalidomide—leprosy	0.000246	0.00093	CcSEcCtD
Paroxetine—Pruritus—Thalidomide—leprosy	0.000243	0.000917	CcSEcCtD
Paroxetine—Diarrhoea—Thalidomide—leprosy	0.000235	0.000887	CcSEcCtD
Paroxetine—Dizziness—Thalidomide—leprosy	0.000227	0.000857	CcSEcCtD
Paroxetine—Vomiting—Thalidomide—leprosy	0.000218	0.000824	CcSEcCtD
Paroxetine—Rash—Thalidomide—leprosy	0.000217	0.000817	CcSEcCtD
Paroxetine—Dermatitis—Thalidomide—leprosy	0.000216	0.000816	CcSEcCtD
Paroxetine—Headache—Thalidomide—leprosy	0.000215	0.000812	CcSEcCtD
Paroxetine—Nausea—Thalidomide—leprosy	0.000204	0.00077	CcSEcCtD
